Abstract
Conflicts of interest (COIs) have always occurred in scientific research, but they did not catch the public’s attention until the 1980s, when the relationship between private companies and academic institutions intensified, due, in part, to legislative changes that encourage technology transfer from the public to the private sector; as well as innovation and growth in biotechnology, pharmaceutical, computers, and other key technologies (OECD 2005). Although most commentaries and guidelines concerning COIs in science focus on research sponsored by private companies, COIs can also arise in other contexts (OECD 2005), for example in Think Tanks. Clifton and Freeman (2021) reported that Think Tanks produce valuable research reports, opinion piece, and expert commentary, however, their work can be compromised by funders, lack of transparency, and COIs. This chapter will analyse and unpack COIs that may arise in a Biotechnology based Think Tank and their possible impact on the public.
Reference10 articles.
1. Organisation for Economic Co-operation and Development (OECD). Managing Conflict of Interest in the Public Sector – A Tool Kit. Paris, France: OECD Publishing; 2005. ISBN 92-64-01822-0. Available from:
2. Clifton E, Freeman R. Restoring trust in the think tank sector. Quincy Briefing. 2021;:1-23. Quincy Institution for Responsible Statecraft. Available from:
3. Nkrumah B. Thin tanks and democratisation in South Africa cosmopolitan civil society: An interdisciplinary journal. 2022;(1):17-31. DOI: 10.5130/ccs.v14.i1.7722
4. Sulla V. Poverty and Equity Brief-South Africa. Sub-Sahara, South Africa: World Bank Group; 2020 [Internet]. Available From:
5. Broad-Base Black Economic Empowerment Act No. 53 of 2003. [Accessed: 25 October 2022]. Available from: